Clinical Trial Update: The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis

View source ↗

Summary

A clinical trial update on a cell-based therapy using C-Kit positive hepatic endothelial cells with MerTK deficiency for nonalcoholic fatty liver disease and no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• C-Kit (+) Hepatic Endothelial Cells with MerTK Deficiency

Snippet

Sponsor: Shanghai East Hospital | Conditions: Non-alcoholic Fatty Liver Disease (NAFLD) | Status: ACTIVE_NOT_RECRUITING